Hospital
Cannon Memorial Hospital
Cannon Memorial Hospital was paid $7.46M by Medicaid between Jan 2018 and Dec 2024, across 117 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 18% of everything it billed.
33Billing provider infoCANNON MEMORIAL HOSPITAL
PICKENS, SC 29671
PICKENS, SC 29671
33aNPI1497744254assigned 10/14/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.46M
24GClaims256,408
24DCodes billed117
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#42 of 115
Median peer was paid$2.47M
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,536 | $970K | |
| 2019 | 42,520 | $910K | |
| 2020 | 31,477 | $649K | |
| 2021 | 36,087 | $770K | |
| 2022 | 40,322 | $1.05M | |
| 2023 | 36,234 | $1.69M | |
| 2024incomplete | 27,232 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 18% | 17,664 | 14,505 | $1.34M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 44,273 | 41,040 | $1.22M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.9% | 16,067 | 14,915 | $661K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.7% | 9,495 | 8,924 | $652K |
| 87430 | 8.0% | 2,773 | 2,686 | $598K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.7% | 4,325 | 3,834 | $427K |
| J7030 | Infusion, normal saline solution , 1000 cc | 4.5% | 1,727 | 1,444 | $334K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.7% | 3,381 | 3,260 | $273K |
| 87077 | 3.0% | 3,375 | 3,135 | $226K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 2,766 | 2,520 | $183K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.4% | 3,600 | 936 | $179K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 9,299 | 7,802 | $144K |
105 more codes
| 81003 | 1.4% | 4,920 | $107K | |
| 80053 | Comprehensive metabolic panel | 1.3% | 8,801 | $97K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 3,905 | $84K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 1,523 | $78K |
| 87088 | <1% | 2,393 | $65K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,417 | $63K |
| 99285 | Emergency room visit (most serious) | <1% | 2,812 | $55K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 992 | $48K |
| 73610 | <1% | 578 | $46K | |
| 73630 | <1% | 615 | $43K | |
| 81025 | <1% | 2,902 | $37K | |
| 87807 | <1% | 180 | $34K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,856 | $33K |
| 81000 | <1% | 2,003 | $33K | |
| 81001 | <1% | 2,411 | $29K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,829 | $29K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,763 | $28K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,527 | $26K |
| J3490 | Unclassified drugs | <1% | 638 | $25K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,537 | $24K |
| 87070 | <1% | 1,775 | $22K | |
| 73030 | <1% | 357 | $21K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,576 | $18K |
| 73130 | <1% | 203 | $17K | |
| 73110 | <1% | 204 | $17K | |
| 73564 | <1% | 427 | $15K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,303 | $15K |
| 82962 | <1% | 411 | $12K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 105 | $10K |
| 72100 | <1% | 258 | $9K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 707 | $8K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 408 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,876 | $6K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 140 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,012 | $6K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 29 | $6K |
| 85027 | <1% | 10,705 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,079 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,840 | $3K |
| 73562 | <1% | 76 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 87 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,350 | $2K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 377 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 169 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 55 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 27 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 540 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,790 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,339 | $1K |
| 83735 | <1% | 1,681 | $920.20 | |
| G0378 | Hospital observation service, per hour | <1% | 26 | $903.37 |
| 94760 | <1% | 1,477 | $833.26 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 27 | $823.10 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 571 | $755.66 |
| 82150 | <1% | 3,675 | $565.56 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,811 | $446.21 |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 12 | $394.86 |
| 80076 | <1% | 2,528 | $393.60 | |
| 74019 | <1% | 12 | $371.08 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,588 | $315.21 |
| 80061 | Lipid panel | <1% | 2,261 | $308.68 |
| 70486 | <1% | 15 | $239.40 | |
| 73502 | <1% | 13 | $160.35 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,005 | $148.23 |
| 84484 | <1% | 3,332 | $138.96 | |
| 74021 | <1% | 34 | $124.77 | |
| 85379 | <1% | 926 | $121.80 | |
| A9270 | Non-covered item or service | <1% | 3,056 | $102.76 |
| 81002 | <1% | 27 | $90.69 | |
| 97161 | <1% | 13 | $66.89 | |
| 83690 | <1% | 4,211 | $42.52 | |
| 71020 | <1% | 19 | $40.20 | |
| 83880 | <1% | 252 | $39.26 | |
| 85610 | <1% | 1,045 | $17.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,532 | $9.65 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 3,451 | $2.84 |
| 87040 | 0% | 734 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 1,116 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 317 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 134 | $0.00 |
| 85730 | 0% | 640 | $0.00 | |
| 83605 | 0% | 811 | $0.00 | |
| 96376 | 0% | 116 | $0.00 | |
| 86140 | 0% | 30 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 70 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 15 | $0.00 |
| 82607 | 0% | 14 | $0.00 | |
| 74022 | 0% | 32 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 27 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 17 | $0.00 |
| 85651 | 0% | 28 | $0.00 | |
| 87205 | 0% | 15 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 504 | $0.00 |
| 87186 | 0% | 910 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 298 | $0.00 |
| 99218 | 0% | 13 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 14 | $0.00 |
| 86703 | 0% | 35 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 32 | $0.00 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 39 | $0.00 |
| 84439 | 0% | 40 | $0.00 | |
| J0595 | Injection, butorphanol tartrate, 1 mg | 0% | 132 | $0.00 |
| 80074 | 0% | 31 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 57 | $0.00 |
| 87075 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCUNNINGHAM, MICHAEL (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Cannon Memorial Hospital | Liberty, SC | $629K |
| Cannon Memorial Hospital | Easley, SC | $608K |
| Cannon Memorial Hospital | Liberty, SC | $313K |
| Florida Keys Area Health Education Center, INC. | Marathon, FL | $137K |
| Cannon Memorial Hospital | Pickens, SC | $96K |
| Cannon Memorial Hospital | Pickens, SC | $47K |
| Florida Keys Area Health Education Center, INC. | Marathon, FL | $35K |
| Cannon Memorial Hospital | Clemson, SC | $5K |
| Cannon Memorial Hospital | Pickens, SC | $589.94 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.